Holen Sie sich die Stockscreener-App
0.8435
0.76%
-0.0065
Schlusskurs vom Vortag:
$0.85
Offen:
$0.8466
24-Stunden-Volumen:
15,911
Relative Volume:
0.04
Marktkapitalisierung:
$5.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.52M
KGV:
-0.0454
EPS:
-18.58
Netto-Cashflow:
$-16.61M
1W Leistung:
-6.19%
1M Leistung:
-32.52%
6M Leistung:
-67.12%
1J Leistung:
-93.00%
1-Tages-Spanne:
$0.831
$0.8574
1-Wochen-Bereich:
$0.8301
$0.95
52-Wochen-Spanne:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Firmenname
Revelation Biosciences Inc
Sektor
Branche
Telefon
650-800-3717
Adresse
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Vergleichen Sie REVB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
0.8435 | 5.04M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.43 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.33 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.43 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.35 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
197.17 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revelation Biosciences Inc Aktie (REVB) Neueste Nachrichten
Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com
How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Revelation Says On Track for FDA Meeting Later This Year - MarketScreener
Revelation Biosciences on track for end-of-phase 1 meeting later this year - TipRanks
Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com
Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com South Africa
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - Weatherford Democrat
Revelation Biosciences (NASDAQ: REVB) Advances Gemini AKI Program With FDA Phase 1 Meeting - Stock Titan
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Valuation Update & Precise Buy Zone Identification - newser.com
How Revelation Biosciences Inc. Equity Warrant stock performs in weak economyGold Moves & Short-Term Trading Alerts - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Using RSI to spot recovery in Revelation Biosciences Inc. Equity Warrant2025 Market Trends & Expert Curated Trade Ideas - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Analyzing recovery setups for Revelation Biosciences Inc. Equity Warrant investorsMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
What catalysts could drive Revelation Biosciences Inc. Equity Warrant stock higher2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com
Can Revelation Biosciences Inc. stock continue upward trendPortfolio Profit Report & Long Hold Capital Preservation Tips - newser.com
Best data tools to analyze Revelation Biosciences Inc. Equity Warrant stockWeekly Loss Report & Weekly Breakout Stock Alerts - newser.com
Why Revelation Biosciences Inc. stock could outperform in 2025 - newser.com
Published on: 2025-11-16 12:31:36 - newser.com
Revelation Biosciences Inc. stock retracement – recovery analysisIPO Watch & Real-Time Chart Pattern Alerts - newser.com
Analyzing Revelation Biosciences Inc. with multi timeframe charts2025 Trading Volume Trends & Reliable Price Action Trade Plans - newser.com
Volume spikes in Revelation Biosciences Inc. stock – what they mean2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 - El Paso Times
Will Revelation Biosciences Inc. Equity Warrant stock outperform Dow Jones indexWeekly Profit Report & Fast Gain Stock Tips - newser.com
Using data filters to optimize entry into Revelation Biosciences Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):